JYNT Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

9.210

Open

9.020

VWAP

9.09

Vol

48.05K

Mkt Cap

130.91M

Low

8.920

Amount

436.75K

EV/EBITDA(TTM)

129.86

Total Shares

14.32M

106.47M

EV/OCF(TTM)

57.91

P/S(TTM)

2.51

The Joint Corp. is a franchisor and operator of chiropractic clinics that uses a private pay, non-insurance, cash-based model. The Company operates the Franchise Operations segment. The Company and its franchisees provide management services to affiliate professional chiropractic practices. The franchise system consists of approximately 811 clinics in operation. It offers a range of membership and wellness packages. It offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. Each patient's records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations.

Events Timeline

(ET)

2026-03-12

16:50:00

Company Reports Q4 Revenue of $15.17M, Beating Expectations

2025-11-06 (ET)

2025-11-06

17:01:00

Joint Corp. unveils new $12M stock buyback initiative

2025-11-06

17:00:15

Joint Corp. supports FY25 adjusted EBITDA forecast of $10.8M-$11.8M

2025-11-06

16:58:37

Joint Corp. announces Q3 earnings per share of 6 cents, surpassing consensus of 0 cents.

2025-11-05 (ET)

2025-11-05

07:43:30

Joint Corp. Board Approves $12 Million Increase in Share Buyback Program

News

5.0

04-14PRnewswire

Nation's Largest Chiropractic Network Welcomes New Executive

5.0

04-14Newsfilter

New Executive Joins Largest Chiropractic Care Network for Growth

7.5

04-07PRnewswire

Miller Subaru Partners with The Joint to Enhance Employee Wellness Benefits

7.5

04-07Newsfilter

Miller Subaru Partners with The Joint to Enhance Employee Wellness Benefits

9.5

03-13seekingalpha

The Joint Corp. Q4 2025 Earnings Call Insights

2.0

03-12NASDAQ.COM

The Joint (JYNT) Q4 2025 Earnings Call Transcript

5 Analyst Rating

Wall Street analysts forecast JYNT stock price to rise

2 Buy

3 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

9.00

Averages

11.33

High

14.00

Current: 0.000

Low

9.00

Averages

11.33

High

14.00

Roth Capital

Buy

downgrade

$14 -> $12

AI Analysis

2026-03-13

Reason

Roth Capital

Price Target

$14 -> $12

AI Analysis

2026-03-13

downgrade

Buy

Reason

Roth Capital lowered the firm's price target on Joint Corp. to $12 from $14 and keeps a Buy rating on the shares. The company's Q4 results exceeded estimates while its 2026 guidance largely mirrors the firm's model, the analyst tells investors in a research note. Roth adds, however, that the management's post-refranchising pro forma model is "underwhelming", even though it continues to see significant long-term upside.

B. Riley

Buy -> Neutral

downgrade

$18 -> $9

2025-11-07

Reason

B. Riley

Price Target

$18 -> $9

2025-11-07

downgrade

Buy -> Neutral

Reason

B. Riley downgraded Joint Corp. to Neutral from Buy with a price target of $9, down from $18. The company's Q3 comps were down 2.0%, reflecting continued softness in new patient acquisition, the analyst tells investors in a research note. The firm Joint's fiscal 2025 as "transitional," as the company tests initiatives and completes refranchising. It cites deteriorating trends for the downgrade.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for JYNT

Unlock Now

Valuation Metrics

The current forward P/E ratio for Joint Corp (JYNT.O) is 21.23, compared to its 5-year average forward P/E of 108.63. For a more detailed relative valuation and DCF analysis to assess Joint Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

108.63

Current PE

21.23

Overvalued PE

208.83

Undervalued PE

8.43

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

30.99

Current EV/EBITDA

25.50

Overvalued EV/EBITDA

59.66

Undervalued EV/EBITDA

2.33

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

3.76

Current PS

2.22

Overvalued PS

7.64

Undervalued PS

-0.12

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

low float medical tech stock

Intellectia · 68 candidates

Market Cap: 50.00M - 5.00BSector: Healthcare, Healthcare Services & Equipment, Pharmaceuticals & Medical ResearchRegion: USPrice: $1.00 - $50.00Beta: ModerateRisk, HighRisk, LowRisk, NegativeBetaList Exchange: XNYS, XNAS, XASEMonthly Average Dollar Volume: >= 300,000Floating Shares: <= 20,000,000

Ticker

Name

Market Cap$

XLO

Xilio Therapeutics Inc

50.19M

LPCN

Lipocine Inc

54.02M

LFVN

LifeVantage Corp

54.88M

CLNN

Clene Inc

63.49M

Outset Medical Inc

64.46M

ACET

Adicet Bio Inc

64.58M

predict biggest winner ticker this year

Intellectia · 73 candidates

Market Cap: 100.00M - 30.00BBeta: HighRiskList Exchange: XNYS, XNAS, XASEOne Month Rise Prob: >= 55One Month Predict Return: >= 10.0%

Ticker

Name

Market Cap$

JMIA

Jumia Technologies AG

1.14B

LII

Lennox International Inc

19.72B

DAVE

Dave Inc

2.39B

LODE

Comstock Inc

196.99M

SMCI

Super Micro Computer Inc

18.29B

FTCI

FTC Solar Inc

141.78M

Whales Holding JYNT

Trading Trends

People Also Watch

Frequently Asked Questions

What is Joint Corp (JYNT) stock price today?

The current price of JYNT is 9.14 USD — it has increased 0.66

What is Joint Corp (JYNT)'s business?

What is the price predicton of JYNT Stock?

Wall Street analysts forecast JYNT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for JYNT is11.33 USD with a low forecast of 9.00 USD and a high forecast of 14.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Joint Corp (JYNT)'s revenue for the last quarter?

Joint Corp revenue for the last quarter amounts to 15.17M USD, increased 3.08

What is Joint Corp (JYNT)'s earnings per share (EPS) for the last quarter?

Joint Corp. EPS for the last quarter amounts to 0.07 USD, decreased

How many employees does Joint Corp (JYNT). have?

Joint Corp (JYNT) has 202 emplpoyees as of April 17 2026.

What is Joint Corp (JYNT) market cap?

Today JYNT has the market capitalization of 130.91M USD.

JYNT Overview

JYNT Overview

Events Timeline

News

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Related Community Screener

Whales Holding JYNT

Trading Trends

People Also Watch

Frequently Asked Questions

What is Joint Corp (JYNT) stock price today?

What is Joint Corp (JYNT)'s business?

What is the price predicton of JYNT Stock?

What is Joint Corp (JYNT)'s revenue for the last quarter?

What is Joint Corp (JYNT)'s earnings per share (EPS) for the last quarter?

How many employees does Joint Corp (JYNT). have?

What is Joint Corp (JYNT) market cap?